News Archive
Displaying the 10 most recent press releases...
Thursday, May 8, 2008
Dana-Farber Cancer Institute Commences Phase 1 Trial With EntreMed’s Selective Kinase Inhibitor
Friday, May 2, 2008
EntreMed Reports First Quarter 2008 Financial Results
Tuesday, April 22, 2008
EntreMed Will Not Seek Shareholder Approval for Reverse Stock Split at Annual Meeting
Wednesday, April 16, 2008
EntreMed Presents MKC-1 and ENMD-1198 Preclinical Data at AACR Annual Meeting
Monday, April 14, 2008
EntreMed’s Kinase Inhibitor, ENMD-2076, Presented During AACR Special Session
Friday, April 11, 2008
EntreMed to Highlight ENMD-2076 Kinase Inhibitor at 2008 AACR Annual Meeting
Wednesday, April 9, 2008
EntreMed Achieves a Key Milestone Through Initiation of ENMD-2076 Clinical Program
Monday, April 7, 2008
Dr. Ronald E. Cape to Retire from EntreMed Board of Directors
Friday, April 4, 2008
EntreMed Receives Nasdaq Deficiency Notice
Wednesday, April 2, 2008
EntreMed Commences Continuous Dosing Clinical Trial For MKC-1